Navigation Links
Targeted therapy extends progression-free survival of patients with advanced ovarian cancer
Date:12/28/2011

PHILADELPHIA, PA (December 28, 2011)Targeted drugs, which block or disrupt particular molecules involved in the growth of tumors, have been shown to be effective treatments against many types of cancer. A new phase 3 clinical trial conducted by the Gynecologic Oncology Group (GOG) showed that a targeted therapy called bevacizumab (Avastin) effectively delayed the progression of advanced ovarian cancer. Patients with newly diagnosed advanced ovarian cancer now typically undergo surgery and chemotherapy, but the new research suggests an additional avenue of treatment. The results of the trial appear in the December 29 issue of the New England Journal of Medicine.

"This approach can be looked upon as a third major component of treatment for ovarian cancer and related malignancies," says Robert A. Burger, MD, lead investigator on the GOG study and director of the Women's Cancer Center at Fox Chase Cancer Center. "We've had the combination of surgical management and cytotoxic chemotherapy for many years, but we haven't really seen anything else in terms of a fundamental class of treatment. This represents a new way for us to control the disease."

The placebo-controlled study, which was sponsored by the National Cancer Institute, enrolled 1,873 patients with previously untreated advanced disease from 336 sites, primarily in the United States, but also in Canada, South Korea, and Japan. The patients either had stage III ovarian cancer that could not be entirely removed with surgery, or stage IV disease, and were randomly assigned to one of three groups. For patients who received bevacizumab with chemotherapy followed by bevacizumab for up to an additional 10 months, the median time until their cancer progressed was 14.1 months, compared to 10.3 months for patients in the control group, who received chemotherapy with a placebo and then continued with a placebo. The net effect was a 28% reduction in the risk of disease of ovarian cancer p
'/>"/>

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-728-7784
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Targeted delivery of losartan reduces liver inflammation and scarring
2. Gene-Targeted Cancer Fix Could Be a Breakthrough
3. Survival in metastatic breast cancer patients is improving: targeted therapies have contributed
4. Targeted agent blocked growth of deadly brain cancer in preclinical studies
5. Kaiser Permanente Southern California to Offer FitOrbit Online Personal Training to Targeted Patients
6. New targeted therapy effective in treating advanced prostate cancer
7. Gene-Targeted Therapy Might Help Prevent Paralysis
8. Site Steering Launches Keyword Targeted Small Business Internet Video Advertising Program That Achieves First Page Search Results Within Days
9. Drug in new class of targeted therapies shows early promise against blood-related cancers
10. Women Smokers Targeted on World No Tobacco Day
11. Targeted immunotherapy shows promise for metastatic breast, pancreatic cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... The benefits of medical imaging far outweigh the risks ... Way, with The Right Radiation Dose. However, overuse and ... Clinic is leading a collaborative effort to ensure a ... online in the Journal of Patient Safety , ... Commission, the Intersociety Accreditation Commission, and the Centers for ...
(Date:7/10/2014)... illness and even death are likely to result if ... Now, however, a team of researchers based at The ... order of infection, the bacteria Streptococcus pneumoniae ... case of the flu. , The researchers discovered ... a bacterial virulence factor, might protect macrophagesa type of ...
(Date:7/10/2014)... brain operates much the same whether active or at ... understanding of schizophrenia, bipolar disorder and other serious mental ... , In newly published research in the journal ... Center for Molecular and Behavioral Neuroscience, determined that the ... basically the same as that of a person performing ...
(Date:7/10/2014)... with localized prostate cancer were more likely to ... less effective treatments and survived for shorter times ... a UCLA study has found. , The negative ... such as bias against the mentally ill, depression,s ... lack of investment in his general health and ...
(Date:7/10/2014)... cheeses and cakes that are just as tempting ... shelves, thanks to fresh insights into how proteins ... texture. , Funded by the Engineering and ... Heriot-Watt University and the University of Edinburgh has ... micro-particles and therefore closely mimic the behaviour of ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic calls for standardization of safe imaging protocols for children 2Health News:Bacterial colonization prior to catching the flu may protect against severe illness 2Health News:Working to loosen the grip of severe mental illness 2Health News:Depressed men with prostate cancer are diagnosed later stage, get less effective therapies 2Health News:Great tasting low-fat cheeses and cakes could soon be on the menu 2
... may be the reason why, researchers say , , THURSDAY, ... may actually have a 30 percent lower risk of ... Cancer Research Center in Seattle. , Levels of estrogen ... of estrogen are associated with an increased risk of ...
... Civic and Community Leaders Kick-off Statewide Initiative to,Advance ... Nov. 6 Lt. Governor Casey Cagle today,applauded ... Screening,Project (MDSP) in Columbus, citing it as a ... country. He made his remarks at the Columbus ...
... Nov. 6 The Northwestern Medical,Faculty Foundation (NMFF) ... services at the Northern Illinois Proton Treatment,and Research ... NIPTRC,and NMFF officials today., NIPTRC, which is ... the,DuPage National Technology Park, will be a world-class, ...
... be Web cast live, LAVAL, QC, Nov. 6 ... today that on Tuesday, November 11, Mr. Gary,Schmid, President ... wholly owned subsidiary of BELLUS Health, will present a ... and,Renshaw 10th Annual Healthcare Conference to be held at ...
... rates and should not influence decisions about how to treat ... of IJCP , the Independent Journal of Clinical ... from Barcelona, Spain, carried out a detailed study of more ... that there were a number of factors that influence survival ...
... and Carly Simon all suffered from stuttering. , Today, ... overcome the handicap, which afflicts 5% of all children ... producing educational, social, and occupational disadvantages. ... from a large-scale international project is providing new insight ...
Cached Medicine News:Health News:Migraine Might Lower Breast Cancer Risk 2Health News:Migraine Might Lower Breast Cancer Risk 3Health News:Columbus Medicare Diabetes Screening Project Cited as Model for State by Lt. Governor Casey Cagle 2Health News:Columbus Medicare Diabetes Screening Project Cited as Model for State by Lt. Governor Casey Cagle 3Health News:Northwestern Medical Faculty Foundation Signs Long-Term Agreement to be the Provider of Doctors for Northern Illinois Proton Treatment and Research Center 2Health News:Northwestern Medical Faculty Foundation Signs Long-Term Agreement to be the Provider of Doctors for Northern Illinois Proton Treatment and Research Center 3Health News:BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference 2Health News:Age is not a key factor in cancer survival, but clinical trials exclude older patients 2Health News:Age is not a key factor in cancer survival, but clinical trials exclude older patients 3Health News:Is stuttering in our DNA? 2
(Date:1/15/2014)... , Jan. 15, 2014 ... research report is available in its ... Markets and Technologies for Advanced Drug ... of Administration ...
(Date:1/14/2014)... , Jan. 14, 2014 InformEx, North America,s ... of high-value chemistry, will hold the 30 th edition ... Convention Center from January 21-24. (Logo: ... from top pharmaceutical, fine chemical and specialty chemical companies will ...
(Date:1/14/2014)... Jan. 14, 2014   NuAire , a manufacturer of ergonomically designed ... Hitachi Koki of Japan to ... North America . NuAire will utilize its network of sales ... Canada to offer assistance in application use, product ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... Imagine the benefits if there was technology that pinpointed ... individual,s type of cancer. No more guessing. No more ... lifesaving technology is on its way to becoming reality. ... Wilshire Oncology Medical Group are yielding positive results. Wilshire ...
... THOR ), a world leader in device-based mechanical ... announced today that it has given notice of its intention ... due 2034 (CUSIP No. 885175AA7) (the "Notes") on May 17, ... outstanding, which can be converted into 7.2 million shares of ...
Cached Medicine Technology:California Oncology Group Uses New Technology to Choose Best Cancer Treatment 2California Oncology Group Uses New Technology to Choose Best Cancer Treatment 3Thoratec Corporation Announces Redemption of Senior Subordinated Convertible Notes Due 2034 2Thoratec Corporation Announces Redemption of Senior Subordinated Convertible Notes Due 2034 3
... Cardiology specific EMR / PM system ... nationwide,enabling more effective patient care decisions.,AcerMed's ... clinicians with critical information on a ... care.,Our Cardiology specific clinical pathways have ...
... in Critical Care & Emergency Medicine. ... cordless, and simple to use device which ... of the pupillary light reflex (PLR). Now ... which are not discernable to the naked ...
... Metrikas pager-sized A1cNow ... technology to provide healthcare ... access to quantitative A1C ... indicator of diabetes management ...
... VenaCure Laser Vein Treatment. It is estimated ... worldwide have varicose veins. In the United States, ... of 60 suffer from painful and unsightly venous ... the capabilities of vascular therapy for the treatment ...
Medicine Products: